glp 1 and diabetic retinopathy The TGA has issued a warning on the potential for high-profile GLP-1 RA medications to cause a rare but severe eye condition. #newsGP https://www1.racgp.org.au/newsgp/clinical/tga-issues-glp-1 -ra-class-wide-safety-update A study in JAMA Network

Cardiovascular risk reduction: Approved for adults with established cardiovascular disease who are also overweight or obese

Myo-Inositol helped build lean muscle, improving metabolic health and fat-burning potential

Known Safety Risks Still Apply Lower doses do not eliminate potential risks associated with GLP-1 receptor agonists, which may include: Pancreatitis Gallbladder disease Thyroid C-cell tumor warning (for certain products) Hypoglycemia when combined with insulin Even smaller amounts affect physiology

GLP Monitor: AI GLP-1 Tracker is your supportive digital companion, designed to take the guesswork and stress out of your GLP1 journey

If you found this article helpful, dont forget to like , share , and Follow to stay up to date on our latest health tips, pharmacy updates, and wellness advice